Carl Zeiss Meditec (ETR:AFX) Given a €93.00 Price Target at Independent Research
Independent Research set a €93.00 ($108.14) price objective on Carl Zeiss Meditec (ETR:AFX) in a research report sent to investors on Thursday morning, Borsen Zeitung reports. The firm currently has a sell rating on the stock.
Other equities research analysts also recently issued research reports about the stock. Kepler Capital Markets set a €80.00 ($93.02) target price on shares of Carl Zeiss Meditec and gave the stock a sell rating in a research note on Monday. Deutsche Bank set a €140.00 ($162.79) target price on shares of Carl Zeiss Meditec and gave the stock a buy rating in a research note on Tuesday. Hauck & Aufhaeuser set a €110.00 ($127.91) target price on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Friday, January 31st. HSBC set a €109.00 ($126.74) target price on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Tuesday, December 10th. Finally, Nord/LB set a €132.00 ($153.49) target price on shares of Carl Zeiss Meditec and gave the stock a buy rating in a research note on Wednesday. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. The stock currently has a consensus rating of Hold and a consensus price target of €111.14 ($129.24).
Shares of AFX traded down €0.60 ($0.70) during mid-day trading on Thursday, hitting €108.90 ($126.63). 127,710 shares of the company’s stock were exchanged, compared to its average volume of 94,405. Carl Zeiss Meditec has a fifty-two week low of €71.25 ($82.85) and a fifty-two week high of €122.10 ($141.98). The firm has a market capitalization of $9.74 billion and a P/E ratio of 57.44. The business’s 50 day moving average is €115.95 and its two-hundred day moving average is €106.71. The company has a current ratio of 3.84, a quick ratio of 3.01 and a debt-to-equity ratio of 4.06.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
See Also: Percentage Decliners
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.